folic acid has been researched along with Choroid Plexus Neoplasms, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, BK; Kranz, DM; Patrick, TA; Roy, EJ; Rund, LA | 1 |
| Kranz, DM; Patrick, TA; Roy, EJ; Zachary, JF | 1 |
2 other study(ies) available for folic acid and Choroid Plexus Neoplasms, Primary
| Article | Year |
|---|---|
Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate.
Topics: Animals; Antibodies, Bispecific; Antibodies, Neoplasm; Antigens, Polyomavirus Transforming; Carrier Proteins; Choroid Plexus Neoplasms; Female; Flow Cytometry; Folate Receptors, GPI-Anchored; Folic Acid; Immunoconjugates; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, Antigen, T-Cell; Receptors, Cell Surface; T-Lymphocytes | 1998 |
Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors.
Topics: Animals; Antibodies, Bispecific; Antigens, Tumor-Associated, Carbohydrate; Carrier Proteins; CD3 Complex; Choroid Plexus Neoplasms; Female; Folate Receptors, GPI-Anchored; Folic Acid; Immunoconjugates; Immunotherapy, Adoptive; Male; Mice; Mice, Inbred C57BL; Receptors, Antigen, T-Cell; Receptors, Cell Surface; Spleen; T-Lymphocytes, Cytotoxic | 1998 |